Power Hour Pulse: From Helium Hype to Quantum Defense — Stocks to Watch into the Close

October 17, 2025

DENVER, Colo., Oct 17, 2025 (247marketnews.com)- As markets grind toward the week’s final bell, today’s Power Hour is brimming with conviction plays, fast-moving catalysts, and late-session setups worth tracking into the afterhours.

Solidion Tech (NASDAQ:STI) is seeing renewed interest after a quiet start to the quarter, as attention shifts toward advanced battery chemistries that solve lithium-ion’s limitations. The company, a provider of solid-state lithium metal battery tech, is being discussed across energy and defense circles due to its non-flammable and high energy density cells.

Solidion is expected to play a larger role in the Department of Defense’s shift to next-gen energy platforms, particularly in drones, tactical vehicles, and portable power for field ops. With competitors like QuantumScape (NYSE:QS) and Solid Power (NASDAQ:SLDP) drawing attention, Solidion’s proprietary electrolyte technologies and DoD ties could become catalysts.

VENU (NYSE:VENU) is setting up for a strong afterhours session following its recent $23M FireSuite sales blitz and plans for a 20+ venue national network of next-gen amphitheaters. Today, the stock is catching a second wind as investors digest fresh renderings, new VIP amenity packages, and $1.3B in active construction.

Backed by Dierks Bentley and Troy Aikman, VENU is being seen as a hybrid of live nation meets real estate, offering infrastructure-backed hospitality exposure. With a goal of $5B in project value over 3 years, Power Hour positioning suggests investors are betting on a breakout sector.

Rekor Systems (NASDAQ:REKR) is perking up in afternoon trade, with its AI-powered roadway intelligence platform gaining visibility in the wake of federal infrastructure discussions. The company’s Rekor One platform enables real-time vehicle recognition, traffic flow analytics, and law enforcement integrations.

As smart infrastructure legislation and urban safety initiatives gain steam, Rekor’s contracts with DOTs and municipalities position it as a small-cap AI sleeper. Today’s late-session volume suggests funds may be quietly accumulating as eyes turn toward upcoming earnings and deployment updates.

While most of the market looks forward, Liberty Oilfield Services (NYSE:LBRT) reminds investors of the now. A leading fracking services provider, LBRT has been trading strong into rising U.S. rig counts and signs of sustained activity in the Permian and Eagle Ford.

Analysts point to improving margins, growing free cash flow, and a shareholder-friendly buyback posture as themes into Q4. Energy equities often see end-of-day strength on commodity tailwinds, watch LBRT into the close.

VirnetX Holding (NYSE:VHC) surged on a powerful volume spike, reigniting interest in its secure communication patents. The move may be tied to speculation around licensing wins or upcoming litigation news related to enterprise secure network access (SNA) and zero trust architecture. VHC remains a polarizing name, long known for its IP enforcement business model, but the company’s relevance is being re-evaluated in a post-cyberattack landscape.

Carbon Revolution (NASDAQ:CREV) continues to rip higher, on growing buzz around its carbon fiber wheels, a lighter, stronger alternative to aluminum. The company is being propelled by rising OEM interest, particularly from EV makers looking to extend range and reduce unsprung weight.

Today’s 21.5M shares traded is nearly 10x its average daily volume, and chatter across EV forums and institutional circles suggest contract speculation may be driving the move. This name is still under the radar, but that may not last long.

Disc Medicine (NASDAQ:IRON) received the first-ever Commissioner’s National Priority Voucher (CNPV) from the FDA for its EPP treatment bitopertin, potentially cutting the review process to just 1–2 months. With Orphan Drug and Rare Pediatric Disease designations already in hand, Disc (NASDAQ:IRON) is now targeting accelerated approval in a debilitating sun-sensitivity disorder that impacts quality of life for thousands. CEO John Quisel emphasized the urgency: “The need for a new therapy… is immense.”

Praxis Precision (NASDAQ:PRAX) is following through after announcing positive topline results from two pivotal Phase 3 studies of ulixacaltamide, its investigational treatment for essential tremor (ET). In Study 1, patients saw a 4.3-point improvement in mADL11 at Week 8 (p<0.0001), with all key secondary endpoints also meeting statistical significance. In Study 2, a randomized withdrawal design, showed 55% of ulixacaltamide-treated patients maintained response, compared to 33% on placebo (p=0.0369).

Praxis has submitted a pre-NDA meeting request with the FDA, eyeing a 2026 NDA filing. With a strong safety profile and demand reflected in 200,000+ study volunteers, the data positions ulixacaltamide as a first-in-class CNS breakthrough.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, including analyst reports, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (CREV, IRON, STI, VHC, VENU, PRAX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.